ClinConnect ClinConnect Logo
Search / Trial NCT04915027

Rehabkompassen® - a Patient-centered Digital Follow-up Tool in the Post-stroke Continuum of Care

Launched by UMEÅ UNIVERSITY · Jun 4, 2021

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Stroke Rehabilitation Patient Tailored Rehabilitation Improvement Of Daily And Social Activity Quality Of Life Health Economy Pragmatic Randomized Clinical Trial

ClinConnect Summary

This clinical trial, called Rehabkompassen®, is looking at a new digital tool designed to help people who have had a stroke. The goal is to see if this tool can improve the way patients recover and manage their daily lives after being discharged from the hospital. By using the Rehabkompassen®, which collects information directly from patients about their health and experiences, researchers hope to create a more personalized rehabilitation plan that can lead to better overall health and quality of life.

To participate in this trial, individuals must be at least 18 years old and have had a stroke within the last four months. They should also have been discharged from a hospital. Participants will be divided into two groups: one will receive standard care, while the other will use the Rehabkompassen® tool along with their usual care. The study will track how effective the tool is in helping people regain their independence and improve their daily activities over a year. This is an exciting opportunity for stroke survivors to potentially benefit from a new approach to rehabilitation that is tailored to their specific needs.

Gender

ALL

Eligibility criteria

  • Inclusion criteria are
  • 1. Adults aged 18 years or older.
  • 2. With a stroke diagnosis
  • Time since stroke onset:
  • 3a) For the big RCT group, Individuals must be within the first 4 months after stroke, starting from Day 1 after the occurrence of the stroke.
  • 3b) For primary care group, Individuals 3 months after stroke
  • Exclusion criteria are
  • 1. Unable to answer the evaluation questions.
  • 2. Unable to see the Rehabkompassen®graph.
  • 3. Not using BankID, an e-identification tool commonly used in Sweden.

About Umeå University

Umeå University, a leading research institution in Sweden, is dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge technology and expert knowledge across various fields to address critical health challenges. Its commitment to ethical standards and patient safety ensures that all clinical trials conducted under its auspices are designed to generate robust scientific evidence, ultimately contributing to improved health outcomes and informed medical practices. Umeå University strives to foster a dynamic research environment that supports the development of new therapies and enhances the understanding of complex health issues.

Locations

Umeå, , Sweden

Patients applied

0 patients applied

Trial Officials

Xiaolei Hu, MD PhD

Principal Investigator

Umeå University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials